$INIS
INTERNATIONAL ISOTOPES INC Stock $inis

$inis Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000151597123000035 Filed on April 06, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$3.090M	$3.150M	$11.18M
YoY Change	10.05%	37.45%	15.73%
Cost Of Revenue	$1.309M	$1.421M	$4.892M
YoY Change	15.81%	55.41%	24.66%
Gross Profit	$1.780M	$1.729M	$6.290M
YoY Change	6.16%	25.53%	9.62%
Gross Profit Margin	57.62%	54.89%	56.25%
Selling, General & Admin	$1.803M	$1.639M	$6.959M
YoY Change	-2.34%	6.76%	13.22%
% of Gross Profit	101.3%	94.79%	110.64%
Research & Development	$124.4K	$91.33K	$533.7K
YoY Change	-39.71%	3.07%	96.43%
% of Gross Profit	6.99%	5.28%	8.49%
Depreciation & Amortization	$87.27K	$86.15K	$374.2K
YoY Change	-26.74%	-38.71%	-35.62%
% of Gross Profit	4.9%	4.98%	5.95%
Operating Expenses	$1.928M	$1.730M	$7.493M
YoY Change	-6.1%	6.56%	16.74%
Operating Profit	-$147.6K	-$1.190K	-$1.203M
YoY Change	-60.76%	-99.52%	76.69%
Interest Expense	$82.98K	-$142.8K	$613.9K
YoY Change	-148.33%	-24.96%	-177.57%
% of Operating Profit
Other Income/Expense, Net	-$482.00	$32.86K	$1.506M
YoY Change	-100.03%	-92.76%	120.44%
Pretax Income	-$148.1K	-$111.1K	$303.2K
YoY Change	-111.8%	-751.17%	-138.44%
Income Tax			$0.00
% Of Pretax Income			0.0%
Net Earnings	-$148.1K	-$111.1K	$303.2K
YoY Change	-111.8%	-751.17%	-133.61%
Net Earnings / Revenue	-4.79%	-3.53%	2.71%
Basic Earnings Per Share
Diluted Earnings Per Share		$0.00
COMMON SHARES
Basic Shares Outstanding	515.0M shares	514.9M shares	510.8M shares
Diluted Shares Outstanding	515.6M shares		510.8M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.281M	$2.376M	$2.376M
YoY Change	4.61%	400.33%	400.33%
Cash & Equivalents	$3.281M	$2.376M	$2.376M
Short-Term Investments
Other Short-Term Assets	$372.4K	$1.023M	$1.023M
YoY Change	-53.01%	1.86%	1.86%
Inventory	$614.5K	$744.8K	$744.8K
Prepaid Expenses
Receivables	$1.556M	$1.597M	$1.597M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.824M	$5.741M	$5.741M
YoY Change	-7.3%	76.22%	76.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.037M	$2.024M	$4.348M
YoY Change	-54.69%	-52.92%	-35.57%
Goodwill	$1.384M	$1.384M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.072M	$1.068M	$1.068M
YoY Change	-0.09%	-0.87%	-0.87%
Total Long-Term Assets	$10.45M	$10.50M	$10.50M
YoY Change	-3.01%	-19.63%	-19.63%
TOTAL ASSETS
Total Short-Term Assets	$5.824M	$5.741M	$5.741M
Total Long-Term Assets	$10.45M	$10.50M	$10.50M
Total Assets	$16.27M	$16.24M	$16.24M
YoY Change	-4.59%	-0.51%	-0.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$420.2K	$382.4K	$382.4K
YoY Change	-54.03%	-73.15%	-73.15%
Accrued Expenses	$1.369M	$1.473M	$1.604M
YoY Change	26.22%	23.83%	22.43%
Deferred Revenue		$879.4K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$10.26K	$23.35K	$648.9K
YoY Change	-98.81%	-91.95%	-49.79%
Total Short-Term Liabilities	$3.469M	$3.515M	$3.515M
YoY Change	-59.45%	-28.77%	-28.77%
LONG-TERM LIABILITIES
Long-Term Debt	$5.097M	$5.100M	$5.100M
YoY Change	648.73%	-5.65%	-5.65%
Other Long-Term Liabilities	$3.256M	$3.287M	$3.287M
YoY Change	-3.56%	0.96%	0.96%
Total Long-Term Liabilities	$8.353M	$8.387M	$8.387M
YoY Change	105.87%	-3.17%	-3.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.469M	$3.515M	$3.515M
Total Long-Term Liabilities	$8.353M	$8.387M	$8.387M
Total Liabilities	$11.82M	$11.90M	$11.90M
YoY Change	-6.27%	-12.46%	-12.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$126.6M	-$126.5M
YoY Change		-0.24%
Common Stock	$5.179M	$5.149M
YoY Change		2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.448M	$4.343M	$4.343M
YoY Change
Total Liabilities & Shareholders Equity	$16.27M	$16.24M	$16.24M
YoY Change	-4.59%	-0.51%	-0.51%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$148.1K	-$111.1K	$303.2K
YoY Change	-111.8%	-751.17%	-133.61%
Depreciation, Depletion And Amortization	$87.27K	$86.15K	$374.2K
YoY Change	-26.74%	-38.71%	-35.62%
Cash From Operating Activities	$981.3K	-$540.6K	-$1.498M
YoY Change	-214.39%	138.97%	825.03%
INVESTING ACTIVITIES
Capital Expenditures	$52.20K	$51.73K	$120.0K
YoY Change	-202.16%	-691.88%	-158.41%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$4.000M
YoY Change	-100.0%
Cash From Investing Activities	-$52.20K	-$51.74K	$3.880M
YoY Change	-101.32%	491.99%	-1988.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$15.36K	-15.24K	-$472.0K
YoY Change	-96.42%	-65.13%	499.75%
NET CHANGE
Cash From Operating Activities	$981.3K	-540.6K	-$1.498M
Cash From Investing Activities	-$52.20K	-51.74K	$3.880M
Cash From Financing Activities	-$15.36K	-15.24K	-$472.0K
Net Change In Cash	$913.7K	-607.5K	$1.910M
YoY Change	-65.67%	118.03%	-528.23%
FREE CASH FLOW
Cash From Operating Activities	$981.3K	-$540.6K	-$1.498M
Capital Expenditures	$52.20K	$51.73K	$120.0K
Free Cash Flow	$929.1K	-$592.3K	-$1.618M
YoY Change	-215.16%	172.37%	-3813.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001038277
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation		usd
CY2021	inis	Warrant Exercises Value WarrantExercisesValue		usd
CY2021	inis	Shares Issued For Acquisition Of Rad Qual SharesIssuedForAcquisitionOfRadQual		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
CY2022	inis	Increase In Operating Lease Rightofuse Asset And Rightofuse Liability For New Lease IncreaseInOperatingLeaseRightofuseAssetAndRightofuseLiabilityForNewLease		usd
CY2022	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations		usd
CY2022	inis	Decrease In Unearned Revenue And Increase In Notes Payable For Repayment Plan DecreaseInUnearnedRevenueAndIncreaseInNotesPayableForRepaymentPlan		usd
CY2022	inis	Increase In Equity And Decrease In Noncontrolling Interest IncreaseInEquityAndDecreaseInNoncontrollingInterest		usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding		shares
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1797978	usd
CY2022	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-22923
CY2022	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL ISOTOPES INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-2763837
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4137 Commerce Circle
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Idaho Falls
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83401
CY2022	dei	City Area Code CityAreaCode	(208)
CY2022	dei	Local Phone Number LocalPhoneNumber	524-5300
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	50000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	514992771	shares
CY2022	dei	Auditor Firm AuditorFirmId	457
CY2022	dei	Auditor Name AuditorName	Haynie & Company
CY2022	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2375817	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	474851	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1596886	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	853675	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	744793	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	924775	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1023129	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1004423	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5740625	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3257724	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	840049	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	830752	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2024486	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4299937	usd
CY2022Q4	inis	Capitalized Lease Disposal Costs Net CapitalizedLeaseDisposalCostsNet	228125	usd
CY2021Q4	inis	Capitalized Lease Disposal Costs Net CapitalizedLeaseDisposalCostsNet	246748	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	12621	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18631	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2311082	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2429622	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1384255	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1384255	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3703353	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3859473	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10503971	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	13069418	usd
CY2022Q4	us-gaap	Assets Assets	16244596	usd
CY2021Q4	us-gaap	Assets Assets	16327142	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	382392	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1424028	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1472504	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1189165	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	879365	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	907953	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	131572	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121069	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5513	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8542	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	620000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	993735	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	23348	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	290017	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3514694	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4934509	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	112500	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1000000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	620000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34406	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57769	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	942378	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	892086	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2832	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8346	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2232244	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2363815	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	4063000	usd
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	4719822	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8387360	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8661838	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11902054	usd
CY2021Q4	us-gaap	Liabilities Liabilities	13596347	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	514889916	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	514889916	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	502584176	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	502584176	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5148899	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5025842	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125654486	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	124469034	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126460843	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126764081	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4342542	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2730795	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16244596	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16327142	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11181988	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9661942	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4891927	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3924142	usd
CY2022	us-gaap	Gross Profit GrossProfit	6290061	usd
CY2021	us-gaap	Gross Profit GrossProfit	5737800	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3390652	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2687735	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3568590	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3459143	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533716	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	271714	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7492958	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	6418592	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202897	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-680792	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2110576	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	683253	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	9502	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	111	usd
CY2022	us-gaap	Interest Expense InterestExpense	613943	usd
CY2021	us-gaap	Interest Expense InterestExpense	791532	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1506135	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-108168	usd
CY2022	us-gaap	Profit Loss ProfitLoss	303238	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-788960	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	113387	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	303238	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-902347	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	510794145	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	477723996	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	510794145	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	477723996	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2887252	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18888	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	207480	usd
CY2021	inis	Stock Issued During Period Value Conversion Of Preferredc Stock StockIssuedDuringPeriodValueConversionOfPreferredcStock	150000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	175000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	84566	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3431	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-788960	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2730795	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	14771	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	204480	usd
CY2022	inis	Warrant Exercises Value WarrantExercisesValue	61800	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	675000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	352458	usd
CY2022	us-gaap	Profit Loss ProfitLoss	303238	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4342542	usd
CY2022	us-gaap	Profit Loss ProfitLoss	303238	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-788960	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	374196	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	581274	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1797978	usd
CY2022	inis	Accretion Of Obligation For Lease Disposal Costs AccretionOfObligationForLeaseDisposalCosts	50292	usd
CY2021	inis	Accretion Of Obligation For Lease Disposal Costs AccretionOfObligationForLeaseDisposalCosts	43266	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	274443	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	401077	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	352458	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	84564	usd
CY2022	inis	Rightofuse Asset Amortization RightofuseAssetAmortization	2528	usd
CY2021	inis	Rightofuse Asset Amortization RightofuseAssetAmortization	-23989	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	743211	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	57547	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	18706	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-243007	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-179982	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	86988	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-28588	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-106249	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-441317	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-499347	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1497719	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-161914	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	120014	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	205474	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3879986	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-205474	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	76571	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	18890	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	101253	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3431	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8543	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7786	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	540032	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	437627	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-472004	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78701	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1910263	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-446089	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1305603	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1751692	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3215866	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1305603	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	54071	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	75786	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	204480	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	207480	usd
CY2021	inis	Increase In Operating Lease Rightofuse Asset And Rightofuse Liability For New Lease IncreaseInOperatingLeaseRightofuseAssetAndRightofuseLiabilityForNewLease	1603	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	675000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	325000	usd
CY2021	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	260715	usd
CY2021	inis	Decrease In Unearned Revenue And Increase In Notes Payable For Repayment Plan DecreaseInUnearnedRevenueAndIncreaseInNotesPayableForRepaymentPlan	146072	usd
CY2021	inis	Increase In Equity And Decrease In Noncontrolling Interest IncreaseInEquityAndDecreaseInNoncontrollingInterest	2423662	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2375817	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	474851	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	840049	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	830752	usd
CY2022Q4	inis	Total Cash Cash Equivalents And Restricted Cash Shown In Statement Of Cash Flows TotalCashCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows	3215866	usd
CY2021Q4	inis	Total Cash Cash Equivalents And Restricted Cash Shown In Statement Of Cash Flows TotalCashCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows	1305603	usd
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	68810000	shares
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4897255	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7268611	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2872769	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2968674	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2375817	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	474851	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	840049	usd
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	830752	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	19000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zCOoxqnQTp2f" style="font: 11pt Times New Roman, Times, Serif; text-indent: 20pt; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-size: 10pt">h)</span> <span style="font-size: 10pt"> <span id="xdx_861_zt3HYrwek509">Use of estimates</span></span></p> <p style="font: 7pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.</p> <p style="font: 7pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533716	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	271714	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2024486	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	352458	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	84564	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	510794145	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	477723996	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	510794145	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	477723996	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24993500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20777500	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7065000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24993500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20777500	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7065000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	65623500	shares
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126460843	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	303238	usd
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3902716	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1497719	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	303238	usd
CY2022	inis	Decrease In Net Income DecreaseInNetIncome	1205585	usd
CY2015	us-gaap	Research And Development Arrangement With Federal Government Description And Terms ResearchAndDevelopmentArrangementWithFederalGovernmentDescriptionAndTerms	In July 2015, the Company announced that it executed an amendment to its Project Participation Agreement (PPA) with the Lea County, New Mexico Board of Commissioners. The PPA granted to the Company direct and indirect assistance for locating its proposed depleted UF6 de-conversion facility in Hobbs, New Mexico. The principal component of assistance was the conveyance of approximately 640 acres of land for construction and operation of the proposed facility.
CY2015	inis	Research And Development Arrangement With Federal Government Description And Additional Terms ResearchAndDevelopmentArrangementWithFederalGovernmentDescriptionAndAdditionalTerms	The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment.
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	145000	usd
CY2021	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	150000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	744793	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	924775	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	744793	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	924775	usd
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	33609	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	39000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4299937	usd
CY2022	us-gaap	Depreciation Depreciation	185193	usd
CY2021	us-gaap	Depreciation Depreciation	398117	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5362628	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	8250	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5370878	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1667525	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3703353	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	164370	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	163180	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	164895	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	164895	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	164895	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	164895	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	164895	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2878878	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3703353	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	643348	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	1010774	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	11439	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	12193	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1677754	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	285159	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	258762	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12066	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6003	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	4172	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	7786	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	649	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1855	usd
CY2022	inis	Total Financing Lease Expense TotalFinancingLeaseExpense	4821	usd
CY2021	inis	Total Financing Lease Expense TotalFinancingLeaseExpense	9641	usd
CY2022	us-gaap	Lease Cost LeaseCost	302046	usd
CY2021	us-gaap	Lease Cost LeaseCost	274406	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1603	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0793	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0863	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	287108	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5881	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	287108	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2929	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	287108	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	287108	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	287108	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2025193	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3460733	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	8810	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1096917	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	465	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2363816	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	8345	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	131572	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5513	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2232244	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2832	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	50090000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	43025000	shares
CY2021	inis	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7065000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	515000	shares
CY2022	inis	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0.12
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	6550000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.11
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20400000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.06
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107250	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3250000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.11
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2552500	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.04
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	362410	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	320000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.07
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20777500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	627615	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8150000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.09
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1200000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.04
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	57000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1734000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.08
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24993500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16716000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.06
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.03
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	280393	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	70366	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	170591	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M17D
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	72207	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-189493	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-72207	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-36981	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	226474	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7736618	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7915642	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7363815	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7497326	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	327803	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	418316	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-372803	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-418316	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	36841000	usd
CY2014Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	On October 2, 2014, the Company signed a ten-year contract with the DOE for the irradiation of cobalt targets for the production of cobalt-60. The Company will be able to purchase cobalt targets for a fixed price per target and with an annual 5% escalation in price. The contract term is October 1, 2014, through September 30, 2024. However, the DOE may end the contract if it determines termination is necessary for the national defense, security or environmental safety of the U.S. If this were to occur, all payments made by the Company would be refunded.
CY2022Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	840049	usd
CY2011Q3	us-gaap	Other Commitments Description OtherCommitmentsDescription	In August 2011, we received land from Lea County, New Mexico, pursuant to a PPA, whereby the land was deeded to us for no monetary consideration. In return, we committed to construct a uranium de-conversion and FEP facility on the land. In order to retain title to the property, we were to begin construction of the de-conversion facility no later than December 31, 2014, and complete Phase I of the project and have hired at least 75 persons to operate the facility no later than December 31, 2015, although commercial operations need not have begun by that date. In 2015 the Company negotiated a modification to the PPA agreement that extended the start of construction date to December 31, 2015, and the hiring milestone to December 31, 2016. Those dates were not met and the Company is currently in the process of renegotiating a second modification to the agreement to further extend those dates. If we do not succeed in reaching an amendment to extend the performance dates in the agreement then we may, at our sole option, either purchase or re-convey the property to Lea County, New Mexico. The purchase price of the property would be $776,078, plus interest at the annual rate of 5.25% from the date of the closing to the date of payment. We have not recorded the value of this property as an asset and will not do so until such time that sufficient progress on the project has been made to meet our obligations under the agreements for permanent transfer of the title.
CY2022	us-gaap	Description Of Defined Contribution Pension And Other Postretirement Plans DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans	The Company has a 401(k) defined-contribution pension plan (the “401(k) Plan”). Employees are eligible to participate in the Plan after completing six months of full-time service. Participants, under provision of Internal Revenue Code § 401(k), may elect to contribute up to $20,500 of their compensation to the 401(k) Plan which includes both before-tax and Roth after-tax contribution options.
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	588105	usd
CY2021	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	260715	usd
CY2021	inis	Obligation For Lease Disposal Cost Accretion Expense Amortization Expense ObligationForLeaseDisposalCostAccretionExpenseAmortizationExpense	-43267	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	892087	usd
CY2022	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	0	usd
CY2022	inis	Obligation For Lease Disposal Cost Accretion Expense Amortization Expense ObligationForLeaseDisposalCostAccretionExpenseAmortizationExpense	-50291	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	942378	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11181988	usd
CY2022	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9661942	usd
CY2021	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	879365	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	907953	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1596886	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	853675	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11181988	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9661942	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	374196	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	581274	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	303238	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-902347	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	120014	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	70474	usd
CY2022Q4	us-gaap	Assets Assets	16244596	usd
CY2021Q4	us-gaap	Assets Assets	16327142	usd

Files In Submission

Name	View Source	Status
inis-20221231_cal.xml	Edgar Link	unprocessable
0001515971-23-000035-index-headers.html	Edgar Link	pending
0001515971-23-000035-index.html	Edgar Link	pending
0001515971-23-000035.txt	Edgar Link	pending
0001515971-23-000035-xbrl.zip	Edgar Link	pending
auditopinion2022_01.jpg	Edgar Link	pending
auditopinion2022_02.jpg	Edgar Link	pending
exhibit103.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_021.jpg	Edgar Link	pending
image_022.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
inis-20221231.xsd	Edgar Link	pending
inis10k123122.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
inis-20221231_pre.xml	Edgar Link	unprocessable
inis-20221231_def.xml	Edgar Link	unprocessable
inis-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
inis10k123122_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INIS
INTERNATIONAL ISOTOPES INC Stock $inis

2023 Q1 Form 10-K Financial Statement

#000151597123000035 Filed on April 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INIS INTERNATIONAL ISOTOPES INC Stock $inis

2023 Q1 Form 10-K Financial Statement

#000151597123000035 Filed on April 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INIS
INTERNATIONAL ISOTOPES INC Stock $inis